Tag: intraocular pressure

May 17, 2017

Aldeyra Therapeutics Reveals Results from ADX-102 Trial

Aldeyra Therapeutics presented the results from their Phase 2 clinical trial of ADX-102 at this years' meeting of the Association...
May 10, 2017

InMed Files Patent for Cannabinoid-Based Glaucoma Treatment

InMed Pharmaceuticals has filed to apply for a provisional patent in the US related to INM-085 as a cannabinoid-based topical...
May 9, 2017

pSivida Reveals Follow-Up Data on Durasert Trial

pSivida announced positive data from a 12-month follow-up on the company's three-year treatment for posterior segment uveitis.
April 27, 2017

Aldeyra Gets First Patient Enrolled in Phase 3 Trial

Aldeyra Therapeutics enrolled the first patient in their Phase 3 clinical trial of ADX-102.
April 25, 2017

Q BioMed Announces Licensing Agreement for Development of Drug to Treat Rare Pediatric Disorder

Q BioMed Inc. (OTCQB: QBIO) and ASDERA LLC today announce a licensing agreement that provides Q BioMed with the worldwide...
February 22, 2017

Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien® in Canada

Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, and Knight Therapeutics Inc....
January 25, 2017

Aldeyra Therapeutics Announces Clinical Development Update for Phase 3 Programs

LAldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...